Lupus anticoagulant and Sneddon's syndrome

European Journal of Neurology

Volumn 4, Issue 4, 1997, Pages 408-412

  Lousa, M ^a   Gobernado, J M ^a   Cervero, C ^a   Perez Corral, F ^a   Pardo, A ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Anticoagulants; Antiphospholipid antibodies; Cerebrovascular disorders; Lupus; Sneddon's syndrome

Indexed keywords

ANTICOAGULANT AGENT; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; SEROLOGY; SNEDDON SYNDROME; VEIN THROMBOSIS;

EID: 0030660192     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.1997.tb00370.x     Document Type: Article

References (32)

1. Antiphospholipid Antibodies in Stroke Study Group (1993) Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology, 43, 2069-2073.
2. Asherson RA and Cervera R (1993) Antiphospholipid syndrome. Journal of Investigative Dermatology, 100, 21-27.
3. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguley E and Hughes GRW (1989a) Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome. American Journal of Medicine, 86, 391-399.
4. Asherson RA, Khamashta MA- Ordi-Ros J, Derksen RHWM, Machin SJ, Path FRC, Barquinero J, Outt HH, Harris EN, Phil M, Vilardell-Torres M and Hughes GRV (1989b) The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine, 68, 366-374.
5. Aznar J, Villa P, Yaya R, Ferrando F, Estelles A, Valles J and Santos T (1993) Sneddon's syndrome and antiphospholipid antibodies. Thrombosis Research, 69, 555-560.
6. Ferro D, Quintarelli C, Valesine G and Violi F (1994) Lupus anticoagulant and increased thrombin generation in patients with systemic lupus erythematous. Blood, 83, 304.
7. Harris EN, Ghavari AE, Boey ML, Patel BM, Mackwoth-Young CG, Leizov S and Hughes GRV (1983) Anticardiolipin antibodies: detect by radioimmunoassay and association with thrombosis in systemic lupus erythematous. Lancet, 2, 1211-1214.
8. Harris EN and Hughes GRV (1987) Standardising the anticardiolipin antibody Test. Lancet, 1, 277.
9. Hess DC, Sheppard JC and Adams RJ (1993) Increased immunoglobulin binding to cerebral endothelium in patient with antiphospholipid antibodies. Stroke, 24, 994-999.
10. Hughes GRV (1984) Connective tissue disease and the skin. Clinical Experimental Dermatology, 9, 535-544.
11. Kalashnikova LA, Nasonov EL, Kusherkbaeva AE and Grachevva LA (1990) Anticardiolipin antibodies and Sneddon's syndrome. Neurology, 40, 464-467.
12. Kalashnikova LA, Nasonov EL, Stoyanovich LZ, Kovalyov VU, Kosheleva NM and Reshetnyak TM (1994) Sneddon's syndrome and the primary antiphospholipid syndrome. Cerebrovascular Disease, 4, 76-82.
13. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ and Hughes GRV (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. New England Journal of Medicine, 332, 993-997.
14. Levine SR, Langer SL, Albers JW and Welch KMA (1988) Sneddon's syndrome: an antiphospholipid antibody syndrome? Neurology, 38, 798-800.
15. Levine SR, Deegan MJ, Futrell M and Welch KMN (1990) Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology, 40, 1181-1189.
16. Levine SR, Brey RB, Sawaya KL, Salowich-Palm L, Kokkinos J, Kostrrzema B, Perry M, Havstad S and Carey J (1995) Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Annals of Neurology, 38, 119-124.
17. Lousa M, Sastre JL, Cancelas JA, Gobernado JM and Pardo A (1994) Study of antiphospholipid antibodies in a patient with Sneddon's syndrome and her family. Stroke, 25, 1071-1074.
18. McNeil HP, Chesterman CN and Krilis SA (1989) Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. British Journal of Haematology, 73, 506-513.
19. Pettee AD, Wasserman BA, Adams NL, McMullen W, Smith HR, Woods SL and Ratnoff OD (1994) Familial Sneddon's syndrome: clinical, hematologic and radiographic findings in two brothers. Neurology, 44, 399-405.
20. Rebollo M, Val JF, Garijo F, Quintana F and Berciano J (1983) Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Brain, 106, 965-979.
21. Scott A and Boyle SS (1986) Sneddon's syndrome. Australian and New Zealand Journal of Medicine, 16, 799-802.
22. Scheleider MA, Nachman RL, Jaffe EA and Coleman M (1976) A clinical study of the lupus anticoagulant. Blood, 48, 499-504.
23. Sempere AP, Martinez E, Bermejo F, Tahoces ML and Cabello A (1992) Sindrome de Sneddon: caracteristicas clinicas y factores etiopatogenicos. Revista Clinica Española, 191, 3-7.
24. Sitzer M, Sohngen D, Siebler M, Specker C, Rademacher J, Janda I, Aulich A and Steinmetz H (1995) Cerebral microembolism in patient with Sneddon's syndrome. Archives of Neurology, 52, 271-275.
25. Sletnes KE, Keirung G and Wisloff F (1990) Quantitation of anticephalin antibodies in a computer-assisted enzyme-liked immunosorbent assay (ELISA): relation to lupus anticoagulant. Thrombosis Research, 57, 235-246.
26. Sneddon IB (1965) Cerebrovascular lesions and livedo reticularis. British Journal of Dermatology, 77, 180-185.
27. Söhngen D, Wehmeier A, Specker C and Schneider W (1994) Antiphospholipid antibodies in systemic lupus erithematous and Sneddon's syndrome. Seminars in Thrombosis and Hemostasis, 20, 55-63.
28. Stockhammer GJ, Felber SR, Aichner FT, Zeiger B, Sepp N and Fritsch PO (1992) Sneddon's syndrome and antiphospholipid antibodies: clarification of a controversy by skin biopsy? Stroke, 23, 1182-1183.
29. Stockhammer GJ, Felber SR, Zeiger B, Sepp N, Birbamer GG, Fritsch PO and Aichner FT (1993) Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients. Stroke, 24, 685-690.
30. Thiagarajan P, Pengo V and Shapiro SS (1986) The use of diluted Russell viper venom time for the diagnosis of lupus anticoagulants. Blood, 68, 869-874.
31. Vargas JA, Yebra M, Pascual ML, Manzano L and Durantez A (1989) Antiphospholipid antibodies and Sneddon's syndrome. American Journal of Medicine, 87, 597.
32. Zelber B, Sepp N, Stockhammer G, Dosch E, Hilty E, Ofner D, Aichner F and Fritsch PO (1993) Sneddon's syndrome: a long-term follow-up of 21 patients. Archives of Dermatology, 129, 437-447.